SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2021 / Cilt: 19 - Sayı: 3

Atopy and Allergic Diseases Have No Impact on the Severity of COVID-19

Semra Demir
Bahauddin ÇOLAKOĞLU
Suna BÜYÜKÖZTÜRK
Ali CAN
Deniz Eyice KARABACAK
Can TÜZER
Asli GELİNCİK
Murat KÖSE
Alpay Medet Alibeyoğlu
Pages
174–182
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the frequency of sensitization to aero- allergens and the allergic diseases were similar, the history of allergic diseases in the family was higher in the severe group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The clinical features of COVID-19 range from asymptomatic disease to severe pneumonia or even death.
📊
Key Findings & Data:Therefore, many researchers have investigated the factors that could affect the severity of COVID-19.
💡
Conclusion & Impact:Although the frequency of sensitization to aero- allergens and the allergic diseases were similar, the history of allergic diseases in the family was higher in the severe group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The clinical features of COVID-19 range from asymptomatic disease to severe pneumonia or even death. Therefore, many researchers have investigated the factors that could affect the severity of COVID-19. We aimed to assess the impact of aero-allergen sensitization and allergic diseases on the severity of COVID-19. Materials and Methods: We included 60 adult patients with symptomatic COVID-19 and allocated them into two groups equal in number as having severe and non-severe COVID-19. We evaluated the demographic features and allergic diseases in addition to clinical, laboratory and radiological findings of COVID-19. Skin prick tests (SPTs) with common aero-allergens, serum total IgE levels and blood eosinophil counts were evaluated 3 months after the patient’s recovery from COVID-19. Results: The mean age of the patients was 52 ± 11 years and 73.3% of the patients were male. There was no significant difference between the two groups in terms of age, gender, smoking habits, obesity and comorbidities. Although the frequency of sensitization to aero- allergens and the allergic diseases were similar, the history of allergic diseases in the family was higher in the severe group (p

🔖

Cite This Article

Demir, S., ÇOLAKOĞLU, B., BÜYÜKÖZTÜRK, S., CAN, A., KARABACAK, D. E., TÜZER, C., GELİNCİK, A., KÖSE, M., Alibeyoğlu, A. M. (2022). Atopy and Allergic Diseases Have No Impact on the Severity of COVID-19. Astım Allerji İmmünoloji, Cilt: 19 - Sayı: 3, 174–182. https://ajindex.com/articles/451089

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report. 2020 Access date: 1 January 2021. Available from:
  2. Azkur AK, Akdis M, Azkur D, Sokolowska M, Veen W, Brügggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020;75: 1564-81
  3. Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief- review of the risk factors for covid-19 severity. Rev Saude Publica 2020;54:60
  4. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS- CoV-2: A systematic review and meta-analysis. Int J Infect Dis 2020;94: 91-5
  5. Romagnani S. Immunologic influences on allergy and the TH1/ TH2 balance. J Allergy Clin Immunol 2004;113:395-400
  6. Yang JM, Koh HY, Moon SY,Yoo IK, Ha EK, You S, et al. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. J Allergy Clin Immunol 2020;146:790- 8
  7. Scala E, Abeni D, Tedeschi A, Manzotti G, Yang B, Borrelli P, et al. Atopic status protects from severe complications ofCOVID-19. Allergy 2021;76:899-902
  8. Shi W, Gao Z, Ding Y, Zhu T, Zhang W, Xu Y. Clinical characteristics of COVID-19 patients combined with allergy. Allergy 2020;75: 2405-8
  9. Wang L, Foer D, Bates DW, Boyce JA, Zhou L. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol 2020;146: 808-12
  10. Pei-Fang Wei, editors. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl) 2020;133(9):1087-95
  11. Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, Luo Y, Gao C, Zeng W. Chest CT severity score: An imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging 2020;2(2):e200047
  12. Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis 2021;80:88-95
  13. Migueres M, Davila I, Frati F, Azpeitia A, Jeanpetit Y, Barrand ML, et al. Types of sensitization to aeroallergens: Definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Transl Allergy 2014;4:16
  14. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang TB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan, China. Allergy 2020;75:1730-41
  15. Licona-Limón P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group